![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![SPI Pharma Corp Ad](https://www.pharmacompass.com/image/flap/spi-pharma-corp-ad-w36-desktop-headergif-63893.gif)
![SPI Pharma Corp Ad](https://www.pharmacompass.com/image/flap/spi-pharma-corp-ad-w36-mobile-headergif-78265.gif)
01 Aurobindo Pharma Limited (1)
02 Emcure Pharmaceuticals Limited (1)
03 Enaltec Labs Pvt Ltd (1)
04 Harman Finochem Limited (1)
05 Harman finochem Limited (1)
06 Hubei Haosun Pharmaceutical Co., Ltd. (1)
07 Indoco Remedies Limited (1)
08 MEDISCA Inc. (1)
09 MSN Laboratories Private Limited (1)
10 Patheon Austria GmbH & CoKG (1)
11 Raks Pharma Pvt. Limited (1)
01 NEOSTIGMINE METHYLSULFATE (1)
02 Neostigmine Methylsulfate (8)
03 Neostigmine methyl sulfate (1)
04 Neostigmine methylsulfate (1)
01 China (1)
02 India (8)
03 U.S.A (2)
52
PharmaCompass offers a list of Neostigmine Methyl Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Neostigmine Methyl Sulfate manufacturer or Neostigmine Methyl Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Neostigmine Methyl Sulfate manufacturer or Neostigmine Methyl Sulfate supplier.
PharmaCompass also assists you with knowing the Neostigmine Methyl Sulfate API Price utilized in the formulation of products. Neostigmine Methyl Sulfate API Price is not always fixed or binding as the Neostigmine Methyl Sulfate Price is obtained through a variety of data sources. The Neostigmine Methyl Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate, including repackagers and relabelers. The FDA regulates Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate supplier is an individual or a company that provides Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate active pharmaceutical ingredient (API) or Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate finished formulations upon request. The Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate suppliers may include Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate API manufacturers, exporters, distributors and traders.
click here to find a list of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate suppliers with NDC on PharmaCompass.
We have 10 companies offering Ammonium, (m-hydroxyphenyl)trimethyl-, methyl sulfate, dimethylcarbamate
Get in contact with the supplier of your choice: